# Cross-Border Jurisdiction Guidance

**Document Classification:** Multi-Jurisdictional Compliance Framework  
**Version:** 3.0  
**Effective Date:** November 2025  
**Scope:** Global Operations (11 Jurisdictions)  
**License:** Apache License 2.0 with NOTICE file  
**Document Governance:** Regulatory Engine v2.5 (Multi-Jurisdictional Intelligence) + Legal Engine v2.2 (Hallucination-Hardened Safeguards) + Legal Engine 2 v1.5 (Systematic Compliance Analysis)

---

## Purpose

This document provides guidance for users deploying AION-BRAIN-derived applications across multiple jurisdictions. Cross-border deployment requires compliance with ALL applicable laws in EACH jurisdiction.

**FUNDAMENTAL PRINCIPLE:** AION-BRAIN provides research frameworks only. Users must engage qualified professionals in each target jurisdiction to ensure compliance with local regulations.

---

## 10-Role Genius Council Validation

This cross-border guidance was developed through multi-perspective analysis:

| Role | Contribution |
|------|--------------|
| General Counsel | Multi-jurisdictional legal architecture |
| Chief Compliance Officer | Cross-border compliance coordination |
| Regulatory Affairs Director | Medical device registration pathways |
| Privacy Officer | International data transfer mechanisms |
| Healthcare Compliance Specialist | Medical AI positioning across jurisdictions |
| Risk Management Officer | Cross-border liability considerations |
| International Legal Counsel | Jurisdiction-specific requirements |
| IP Counsel | International IP protection strategies |
| Ethics Counsel | Cross-cultural professional boundaries |
| Terms & Governance Specialist | Multi-jurisdictional terms applicability |

---

## Covered Jurisdictions

### Medical Device Regulatory Authorities

| Jurisdiction | Authority | Framework Document |
|--------------|-----------|-------------------|
| United States | FDA | [FDA-REGULATORY-STATUS.md](../FDA-REGULATORY-STATUS.md) |
| European Union | EMA / Notified Bodies | [EU-MDR-COMPLIANCE.md](../INTERNATIONAL-COMPLIANCE/EU-MDR-COMPLIANCE.md) |
| United Kingdom | MHRA | [UK-MHRA-GUIDANCE.md](../INTERNATIONAL-COMPLIANCE/UK-MHRA-GUIDANCE.md) |
| Canada | Health Canada | [HEALTH-CANADA-REQUIREMENTS.md](../INTERNATIONAL-COMPLIANCE/HEALTH-CANADA-REQUIREMENTS.md) |
| Japan | PMDA | [JAPAN-PMDA-STANDARDS.md](../INTERNATIONAL-COMPLIANCE/JAPAN-PMDA-STANDARDS.md) |
| China | NMPA | [CHINA-NMPA-REGULATIONS.md](../INTERNATIONAL-COMPLIANCE/CHINA-NMPA-REGULATIONS.md) |
| Australia | TGA | [AUSTRALIA-TGA-FRAMEWORK.md](../INTERNATIONAL-COMPLIANCE/AUSTRALIA-TGA-FRAMEWORK.md) |
| India | CDSCO | [INDIA-CDSCO-FRAMEWORK.md](../INTERNATIONAL-COMPLIANCE/INDIA-CDSCO-FRAMEWORK.md) |
| South Korea | MFDS | [SOUTH-KOREA-MFDS-FRAMEWORK.md](../INTERNATIONAL-COMPLIANCE/SOUTH-KOREA-MFDS-FRAMEWORK.md) |
| Brazil | ANVISA | [BRAZIL-ANVISA-FRAMEWORK.md](../INTERNATIONAL-COMPLIANCE/BRAZIL-ANVISA-FRAMEWORK.md) |
| South Africa | SAHPRA | [SOUTH-AFRICA-SAHPRA-FRAMEWORK.md](../INTERNATIONAL-COMPLIANCE/SOUTH-AFRICA-SAHPRA-FRAMEWORK.md) |

---

## Jurisdictional Complexity Framework

### Compliance Layering

| Layer | Description | Examples |
|-------|-------------|----------|
| International | Global frameworks and treaties | IMDRF, WHO, OECD principles |
| Regional | Multi-country agreements | EU regulations, ASEAN frameworks |
| National | Country-specific laws | FDA (US), NMPA (China), MFDS (Korea) |
| State/Provincial | Sub-national requirements | US state laws, Indian state regulations |
| Local | Municipal or local rules | Practice restrictions, licensing boards |
| Professional | Ethical codes and standards | Medical boards, bar associations |

### Multi-Jurisdictional Complexity Matrix

| Factor | Single Jurisdiction | Multi-Jurisdictional |
|--------|---------------------|---------------------|
| Regulatory Pathway | One approval | Multiple parallel approvals |
| Professional Licensing | Local license | License per jurisdiction |
| Data Protection | One framework | Multiple overlapping frameworks |
| Language Requirements | One language | Multiple translations required |
| Local Representation | May not be required | Required in most jurisdictions |
| Vigilance Reporting | One authority | Each national authority |

---

## Domain-Specific Cross-Border Considerations

### Medical AI

| Consideration | Guidance |
|---------------|----------|
| Device Registration | Register in EACH country separately |
| Clinical Evidence | May need local clinical data |
| Language | Translate labeling and IFU |
| Local Representative | Appoint in each jurisdiction |
| Vigilance | Report to each national authority |
| Classification | Re-classify per local rules |

### Jurisdiction-Specific Medical AI Requirements

| Jurisdiction | Key Requirement |
|--------------|-----------------|
| United States | FDA 510(k) or De Novo pathway |
| European Union | CE marking under EU MDR |
| United Kingdom | UKCA marking post-Brexit |
| Japan | PMDA Shonin approval |
| China | NMPA registration + data localization |
| India | CDSCO with Algorithmic Change Protocol |
| South Korea | MFDS approval + nHTA for reimbursement |
| Brazil | ANVISA RDC 751/2022 classification |
| South Africa | SAHPRA + reference jurisdiction approval |

### Legal AI

| Consideration | Guidance |
|---------------|----------|
| Bar Admission | Licensed attorneys required per jurisdiction |
| UPL | Unauthorized practice rules vary significantly |
| Privilege | Attorney-client privilege differs by country |
| Conflicts | Multi-jurisdictional conflict rules |
| Ethics | Professional conduct rules vary |

### Financial AI

| Consideration | Guidance |
|---------------|----------|
| Licensing | Registration in each jurisdiction |
| Conduct Rules | Fiduciary standards vary |
| Disclosures | Different disclosure requirements |
| Suitability | Standards differ by country |
| AML/KYC | Anti-money laundering varies |

---

## Data Protection Cross-Border Framework

### International Data Transfers by Jurisdiction

| From | To | Mechanism Required |
|------|----|--------------------|
| EU/EEA | Adequate country | No additional mechanism |
| EU/EEA | Non-adequate country | SCCs + TIA + supplementary measures |
| UK | Adequate country | No additional mechanism |
| UK | Non-adequate country | IDTA or UK Addendum to SCCs |
| China | Outside China | CAC security assessment or standard contract |
| India | Outside India | Per DPDP Act (implementation pending) |
| South Korea | Outside Korea | Consent or APEC CBPR |
| Brazil | Outside Brazil | LGPD adequacy or contractual safeguards |
| South Africa | Outside SA | POPIA consent or adequacy |

### Key Data Protection Frameworks

| Jurisdiction | Framework | Cross-Border Mechanism |
|--------------|-----------|------------------------|
| EU/EEA | GDPR | Adequacy, SCCs, BCRs |
| UK | UK GDPR | UK adequacy, IDTA |
| US | Sectoral | No comprehensive federal law |
| China | PIPL, CSL | Security assessment, standard contract |
| Japan | APPI | APEC CBPR, adequacy |
| India | DPDP Act 2023 | Implementation pending |
| South Korea | PIPA | Consent, APEC CBPR |
| Brazil | LGPD | Adequacy, SCCs-equivalent |
| South Africa | POPIA | Consent, adequacy |
| Australia | Privacy Act | APP 8 requirements |

---

## Professional Licensing Cross-Border

### Medical Practice

| Jurisdiction | License Required | Telemedicine Rules |
|--------------|------------------|-------------------|
| United States | State medical license | Varies by state |
| European Union | National license | Cross-border recognition varies |
| United Kingdom | GMC registration | UK-specific rules |
| Canada | Provincial license | Provincial variation |
| Japan | Japanese medical license | Strict requirements |
| China | Chinese medical license | Foreign practice restricted |
| India | MCI/NMC registration | Telemedicine guidelines 2020 |
| South Korea | Korean medical license | K-medical act compliance |
| Brazil | CRM registration | Regional variation |
| South Africa | HPCSA registration | National requirements |

### Legal Practice

| Jurisdiction | Requirement | Foreign Lawyer Rules |
|--------------|-------------|---------------------|
| United States | State bar admission | Limited practice rules |
| European Union | National bar | Services directive |
| United Kingdom | SRA/Bar registration | Foreign lawyer registration |
| Canada | Provincial law society | NCA assessment |
| Japan | Japan bar association | Foreign lawyer registration |
| China | Chinese bar | Restricted to advisory |
| India | Bar Council of India | Foreign firms restricted |
| South Korea | Korean bar | Limited foreign practice |
| Brazil | OAB registration | Foreign lawyer restrictions |
| South Africa | Legal Practice Council | Foreign lawyer registration |

---

## Compliance Strategy

### Multi-Jurisdictional Compliance Phases

| Phase | Actions |
|-------|---------|
| Phase 1: Mapping | Identify target jurisdictions, map applicable regulations, identify overlaps and conflicts, prioritize by market importance |
| Phase 2: Analysis | Determine requirements per jurisdiction, identify highest common standard, assess local variation needs, document regulatory strategy |
| Phase 3: Implementation | Build compliance into design, engage local expertise, establish local representatives, implement jurisdiction-specific measures |
| Phase 4: Maintenance | Monitor regulatory changes, update compliance, maintain documentation, conduct periodic reviews |

### Highest Common Standard Approach

| Domain | Strictest Jurisdiction | Standard |
|--------|----------------------|----------|
| Medical Device Safety | EU MDR | Clinical evidence requirements |
| Data Protection | EU GDPR | Comprehensive privacy rights |
| AI Transparency | EU AI Act | Risk-based classification |
| Professional Oversight | All jurisdictions | Licensed professional required |

---

## Expert Engagement

### Required Expertise by Domain

| Domain | Expert Type | Purpose |
|--------|------------|---------|
| Regulatory | Regulatory affairs professional | Device registration, approvals |
| Legal | International law counsel | Cross-border legal issues |
| Privacy | Data protection officer | GDPR, PIPL, LGPD compliance |
| Tax | International tax advisor | Cross-border tax implications |
| IP | IP counsel | Patent/trademark protection |
| Local | In-country counsel | Jurisdiction-specific requirements |

---

## Choice of Law and Forum

### AION-BRAIN Position

AION-BRAIN is governed by the law specified in the Terms of Use. However:

- Users must comply with local laws regardless
- Local mandatory laws may override choice of law
- Consumer protection laws may apply locally
- Regulatory requirements are jurisdiction-specific

### User Considerations

| Factor | Analysis |
|--------|----------|
| Primary Market | Where most users are located |
| Highest Standard | Consider complying with strictest requirements |
| Local Presence | Physical presence creates jurisdiction |
| User Location | May determine applicable law |
| Enforcement | Where can claims be brought |

---

## Document Control

| Version | Date | Changes |
|---------|------|---------|
| 1.0 | November 2025 | Initial draft |
| 2.0 | November 2025 | Comprehensive international framework |
| 3.0 | November 2025 | Added India, South Korea, Brazil, South Africa; 10-role Genius Council; 3-engine integration |

---

*This document is part of the AION-BRAIN legal framework. All materials are provided under Apache License 2.0. See [LICENSE-EXPLANATION.md](../LICENSE-EXPLANATION.md) for licensing details. This is not legal advice; engage qualified professionals in each target jurisdiction.*
